User profiles for D. M. Gendoo

Deena MA Gendoo

Associate Professor in Computational Biology, University of Birmingham
Verified email at bham.ac.uk
Cited by 1806

Circulating tumour DNA detects somatic variants contributing to spatial and temporal intratumoural heterogeneity in head and neck squamous cell carcinoma

…, J Brooks, N Batis, AD Beggs, DM Gendoo… - Frontiers in …, 2024 - frontiersin.org
Background - As circulating tumour DNA (ctDNA) liquid biopsy analysis is increasingly
incorporated into modern oncological practice, establishing the impact of genomic intra-tumoural …

[PDF][PDF] The common analgesic paracetamol enhances the anti-tumour activity of decitabine through exacerbation of oxidative stress

…, Y Jiang, SJ Clokie, H Mehanna, P Garcia, DM Gendoo… - 2020 - scholar.archive.org
The common analgesic paracetamol enhances the anti-tumour activity of decitabine through
exacerbation of oxidative stress Conf Page 1 1 The common analgesic paracetamol enhances …

[PDF][PDF] Integrated (epi)-genomic analyses identify subgroup-specific therapeutic targets in CNS rhabdoid tumors

…, L Letourneau, M Bourgey, M Yu, DMA Gendoo… - Cancer cell, 2016 - cell.com
We recently reported that atypical teratoid rhabdoid tumors (ATRTs) comprise at least two
transcriptional subtypes with different clinical outcomes; however, the mechanisms underlying …

[HTML][HTML] MM2S: personalized diagnosis of medulloblastoma patients and model systems

DMA Gendoo, B Haibe-Kains - Source Code for Biology and Medicine, 2016 - Springer
Background Medulloblastoma (MB) is a highly malignant and heterogeneous brain tumour
that is the most common cause of cancer-related deaths in children. Increasing availability of …

[HTML][HTML] The anti-tumour activity of DNA methylation inhibitor 5-aza-2′-deoxycytidine is enhanced by the common analgesic paracetamol through induction of …

…, SJH Clokie, H Mehanna, P Garcia, DMA Gendoo… - Cancer Letters, 2021 - Elsevier
The DNA demethylating agent 5-aza-2′-deoxycytidine (DAC, decitabine) has anti-cancer
therapeutic potential, but its clinical efficacy is hindered by DNA damage-related side effects …

Public data and open source tools for multi-assay genomic investigation of disease

…, N El-Hachem, Z Safikhani, DMA Gendoo… - Briefings in …, 2016 - academic.oup.com
… Deena MA Gendoo is a postdoctoral research fellow at the Princess Margaret Cancer Centre,
Canada. Her research focuses on translational bioinformatics in multiple cancer types, as …

Bioinformatic sequence and structural analysis for Amyloidogenicity in Prions and other proteins

D Gendoo - 2012 - escholarship.mcgill.ca
Detection of amyloidogenic peptides or domains in proteins is of paramount importance towards
understanding their role in amyloidosis in conformational diseases. This thesis explores …

[HTML][HTML] Modeling germline mutations in pineoblastoma uncovers lysosome disruption-based therapy

PED Chung, DMA Gendoo… - Nature …, 2020 - nature.com
Pineoblastoma is a rare pediatric cancer induced by germline mutations in the tumor
suppressors RB1 or DICER1. Presence of leptomeningeal metastases is indicative of poor …

[HTML][HTML] A subgroup of microRNAs defines PTEN-deficient, triple-negative breast cancer patients with poorest prognosis and alterations in RB1, MYC, and Wnt …

DY Wang, DMA Gendoo, Y Ben-David… - Breast cancer …, 2019 - Springer
Background Triple-negative breast cancer (TNBC) represents a heterogeneous group of ER-
and HER2-negative tumors with poor clinical outcome. We recently reported that Pten-loss …

[HTML][HTML] Ulinastatin administration is associated with a lower incidence of acute kidney injury after cardiac surgery: a propensity score matched study

X Wan, X Xie, Y Gendoo, X Chen, X Ji, C Cao - Critical Care, 2016 - Springer
Background Systemic inflammation is involved in the development of acute kidney injury (AKI)
after cardiac surgery with cardiopulmonary bypass (CPB). Ulinastatin, a urinary trypsin …